Rooftop

Rooftop Bio is a synthetic biology company developing a platform for programmable medicines designed to provide precise control over therapeutic activity. The company's technology utilizes genetic circuits and RNA-based logic to ensure that drugs are only active in specific target cells or under defined physiological conditions. This "smart" drug approach aims to overcome the toxicity and off-target effects associated with traditional systemic therapies. Founded by pioneers in the field of synthetic biology, Rooftop Bio is currently in the pre-clinical stage, focusing on building a robust pipeline of responsive genetic medicines.